These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 17052882

  • 21. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
    Streit JM, Jones RN, Sader HS, Fritsche TR.
    Int J Antimicrob Agents; 2004 Aug; 24(2):111-8. PubMed ID: 15288308
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
    Zarakolu P, Hasçelik G, Unal S.
    Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
    [Abstract] [Full Text] [Related]

  • 24. MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from Europe: comparison of antibiotic susceptibilities between countries and centre types. MYSTIC Study Group (European centres only).
    Goossens H.
    J Antimicrob Chemother; 2000 Sep; 46 Suppl T2():39-52. PubMed ID: 11065147
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004).
    Rhomberg PR, Fritsche TR, Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2006 Apr; 54(4):249-57. PubMed ID: 16466890
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Surveillance for antimicrobial resistance among clinical isolates of gram-negative bacteria from intensive care unit patients in China, 1996 to 2002.
    Wang H, Chen M, China Nosocomial Pathogens Resistance Surveillance Study Group.
    Diagn Microbiol Infect Dis; 2005 Mar; 51(3):201-8. PubMed ID: 15766607
    [Abstract] [Full Text] [Related]

  • 34. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
    Fraenkel CJ, Ullberg M, Bernander S, Ericson E, Larsson P, Rydberg J, Törnqvist E, Melhus A.
    Scand J Infect Dis; 2006 Mar; 38(10):853-9. PubMed ID: 17008228
    [Abstract] [Full Text] [Related]

  • 35. Susceptibility of meropenem and comparators tested against 30,634 Enterobacteriaceae isolated in the MYSTIC Programme (1997-2003).
    Turner PJ.
    Diagn Microbiol Infect Dis; 2004 Dec; 50(4):291-3. PubMed ID: 15582303
    [Abstract] [Full Text] [Related]

  • 36. [Antimicrobial resistance of Gram-negative bacilli isolated from 13 teaching hospitals across China].
    Wang Q, Zhao CJ, Wang H, Yu YS, Zhu ZH, Chu YZ, Sun ZY, Hu ZD, Xu XL, Liao K, Xu YC, Zhang LY, Mei YN, Yang B, Ni YX.
    Zhonghua Yi Xue Za Zhi; 2013 May 14; 93(18):1388-96. PubMed ID: 24025503
    [Abstract] [Full Text] [Related]

  • 37. Investigation of the antibiotic susceptibility patterns of pathogens causing nosocomial infections.
    Yaman A, Tasova Y, Kibar F, Inal AS, Saltoglu N, Buyukcelik O, Kurtaran B, Dundar IH.
    Saudi Med J; 2004 Oct 14; 25(10):1403-9. PubMed ID: 15494811
    [Abstract] [Full Text] [Related]

  • 38. In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections at a medical center in Taiwan: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2002-2006.
    Chen WY, Jang TN, Huang CH, Hsueh PR.
    J Microbiol Immunol Infect; 2009 Aug 14; 42(4):317-23. PubMed ID: 19949755
    [Abstract] [Full Text] [Related]

  • 39. The OPTAMA programme: utilizing MYSTIC (2002) to predict critical pharmacodynamic target attainment against nosocomial pathogens in Europe.
    Masterton RG, Kuti JL, Turner PJ, Nicolau DP.
    J Antimicrob Chemother; 2005 Jan 14; 55(1):71-7. PubMed ID: 15574471
    [Abstract] [Full Text] [Related]

  • 40. Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Pfaller MA, Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2006 Sep 14; 56(1):63-8. PubMed ID: 16650951
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.